Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

Earendil Labs, an expert in AI-driven research and development of next-generation biologics therapeutics, and Sanofi have ...

When we think about the protection that can be provided by a comprehensive immunization plan, we think in terms of lifetimes. It’s vital that we also remember the important moments that make up each ...

Despite 2024 top-line numbers some analysts found disappointing, L’Oréal doubled down on profits, achieving record gross and operating margins. Excluding Aēsop, acquired from Natura&Co. in 2023, its ...

Sanofi is teaming up with a private biotech in Delaware on a pair of bispecific antibodies for autoimmune and inflammatory ...